# A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

> **NCT01370655** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 46 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK-7145
- **DRUG:** Hydrochlorothiazide (HCTZ)
- **DRUG:** Placebo to MK-7145
- **DRUG:** Placebo to HCTZ

## Key facts

- **NCT ID:** NCT01370655
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-15
- **Primary completion:** 2011-12-19
- **Final completion:** 2012-01-26
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370655, "A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01370655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*